Hodaka Yamakado

Kyoto, 6068507, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Frontal and temporal hyper-perfusion in Parkinson's disease with subjective cognitive decline.

Frontal and temporal hyper-perfusion in Parkinson's disease with subjective cognitive decline.

Journal: Parkinsonism & related disorders

Published: March 24, 2026

Parkinson's Disease Cell Transplantation Therapy: A New Dawn With Pluripotent Stem Cell-Based Therapy.

Parkinson's Disease Cell Transplantation Therapy: A New Dawn With Pluripotent Stem Cell-Based Therapy.

Journal: Journal of neurochemistry

Published: January 06, 2026

Evaluation of a commercial AI-assisted cell counting software for dopaminergic neurons across species.

Evaluation of a commercial AI-assisted cell counting software for dopaminergic neurons across species.

Journal: PloS one

Published: September 29, 2025

Perampanel Blocks Transsynaptic α-Synuclein Propagation and Neurodegeneration in a Mouse Model of Lewy Body Disease.

Perampanel Blocks Transsynaptic α-Synuclein Propagation and Neurodegeneration in a Mouse Model of Lewy Body Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: June 13, 2025

Impact of α-synuclein fibril structure on seeding activity in experimental models of Parkinson's disease.

Impact of α-synuclein fibril structure on seeding activity in experimental models of Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: May 25, 2025

The Gut-Brain Axis Based on α-Synuclein Propagation-Clinical, Neuropathological, and Experimental Evidence.

The Gut-Brain Axis Based on α-Synuclein Propagation-Clinical, Neuropathological, and Experimental Evidence.

Journal: International journal of molecular sciences

Published: April 01, 2025

Expectations regarding regenerative medicine and attitudes toward invasive surgical therapies in patients with Parkinson's disease: A cross-sectional survey.

Expectations regarding regenerative medicine and attitudes toward invasive surgical therapies in patients with Parkinson's disease: A cross-sectional survey.

Journal: Clinical parkinsonism & related disorders

Published: March 07, 2025

Enhanced alpha-synuclein pathology and exacerbated motor dysfunction in alpha-synuclein transgenic mice with autophagy deficiency.

Enhanced alpha-synuclein pathology and exacerbated motor dysfunction in alpha-synuclein transgenic mice with autophagy deficiency.

Journal: Biochemical and biophysical research communications

Published: February 04, 2025

Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives.

Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives.

Journal: Parkinsonism & related disorders

Published: January 11, 2025

Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's disease.

Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's disease.

Journal: Cell stem cell

Published: December 19, 2024

Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease.

Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease.

Journal: European journal of neurology

Published: October 09, 2024

Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease.

Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease.

Journal: Nature

Published: August 09, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026